Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

4-7-8 Breathing Exercises for Stress, Well-Being, and Quality of Life in Newly Diagnosed Type 2 Diabetes

14. november 2026 oppdatert av: EMRE ERKAL, Artvin Coruh University

Effects of 4-7-8 Breathing Exercises on Perceived Stress, Mental Well-Being, and Quality of Life in Newly Diagnosed Patients With Type 2 Diabetes

This randomized controlled trial aims to evaluate the effects of 4-7-8 breathing exercises on perceived stress, mental well-being, and quality of life in newly diagnosed patients with type 2 diabetes mellitus.

The study will be conducted at the Internal Medicine Outpatient Clinic of Kayseri City Hospital, Türkiye. A total of 60 patients aged 18-65 years who have been newly diagnosed with type 2 diabetes mellitus and have HbA1c levels of 8% or higher will be enrolled. Participants will be randomly assigned to either the intervention group (n=30) or the control group (n=30) using simple randomization.

Participants in the intervention group will perform 4-7-8 breathing exercises twice daily, in the morning and evening, for four weeks, in addition to receiving routine diabetes treatment. The breathing technique involves inhaling through the nose for 4 seconds, holding the breath for 7 seconds, and exhaling through the mouth for 8 seconds. Participants will be instructed to perform four sets per session. Participants in the control group will continue receiving routine diabetes treatment without any additional breathing exercises.

Data will be collected at baseline and at the end of the four-week intervention using the Perceived Stress Scale (PSS-14), the World Health Organization-Five Well-Being Index (WHO-5), and the Short Form-36 Health Survey (SF-36).

The study will investigate whether 4-7-8 breathing exercises improve perceived stress, mental well-being, and quality of life in newly diagnosed patients with type 2 diabetes mellitus compared with routine care alone.

Studieoversikt

Status

Har ikke rekruttert ennå

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease that requires continuous treatment, lifestyle modifications, and self-management. Receiving a new diagnosis of T2DM may lead to psychological distress, uncertainty, and difficulties adapting to disease-related responsibilities. These challenges may negatively affect perceived stress, mental well-being, and quality of life during the early stages of disease management.

Controlled breathing exercises are non-pharmacological interventions that may help regulate physiological and psychological responses to stress. The 4-7-8 breathing technique involves a structured breathing pattern designed to promote relaxation through controlled inhalation, breath-holding, and prolonged exhalation. Although previous studies have investigated various breathing techniques in individuals with T2DM, evidence regarding the effects of 4-7-8 breathing exercises specifically in newly diagnosed patients remains limited.

This study is designed as a two-arm, parallel-group randomized controlled trial to investigate the effectiveness of 4-7-8 breathing exercises as a complementary intervention alongside routine diabetes treatment.

Following eligibility assessment and informed consent, participants will complete baseline assessments and be randomly allocated to the intervention or control group. Participants assigned to the intervention group will receive instructions on performing the 4-7-8 breathing technique and will practice the exercises twice daily for four weeks. Participants in both groups will continue their routine diabetes treatment throughout the study.

The study will assess three patient-reported outcomes: perceived stress, mental well-being, and health-related quality of life. Perceived stress will be evaluated using the 14-item Perceived Stress Scale (PSS-14), with higher scores indicating greater perceived stress. Mental well-being will be assessed using the WHO-5 Well-Being Index, with higher scores indicating better well-being. Health-related quality of life will be measured using the SF-36 Health Survey, which evaluates eight dimensions of physical and mental health.

Outcome assessments will be conducted at baseline and after the four-week intervention. The collected data will be analyzed using appropriate statistical methods to examine changes within groups and differences between groups.

The findings are expected to contribute to the evidence regarding the potential role of 4-7-8 breathing exercises as a simple, accessible, and non-pharmacological supportive intervention for patients newly diagnosed with T2DM.

Studietype

Intervensjonell

Registrering (Antatt)

60

Fase

  • Ikke aktuelt

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Being between 18 and 65 years of age.
  • Having a new diagnosis of type 2 diabetes mellitus.
  • Having an HbA1c level of ≥8%.
  • Having initiated insulin and/or oral antidiabetic treatment.
  • Having no communication difficulties.
  • Having no respiratory disorders (e.g., asthma or chronic obstructive pulmonary disease).
  • Being willing to participate in the study.

Exclusion Criteria:

  • Presence of respiratory disorders, such as asthma or chronic obstructive pulmonary disease (COPD).
  • Presence of communication difficulties that prevent participation in the study.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: 4-7-8 Breathing Exercise Group

Participants in the experimental group will perform 4-7-8 breathing exercises twice daily (morning and evening), with four sets per session, for four weeks. Each breathing cycle consists of inhaling through the nose for 4 seconds, holding the breath for 7 seconds, and exhaling slowly through the mouth for 8 seconds. Participants will continue receiving their routine diabetes treatment throughout the intervention period.

Participants in the intervention group will perform the 4-7-8 breathing exercise for four weeks in addition to their routine diabetes treatment. The technique consists of three consecutive steps: (1) exhaling completely through the mouth while making a whooshing sound; (2) closing the mouth, inhaling quietly through the nose for 4 seconds, and holding the breath for 7 seconds; and (3) exhaling slowly through the mouth for 8 seconds while making a whooshing sound. Participants will be instructed to perform the exercise twice daily, in the morning and evening, with four sets per session. Routine diabetes treatment will continue throughout the intervention period.

Ingen inngripen: Routine Care Group

Participants in the control group will continue receiving routine diabetes treatment without performing 4-7-8 breathing exercises or receiving any additional breathing intervention during the four-week study period.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Perceived Stress Scale (PSS-14) Score From Baseline to Week 4
Tidsramme: Baseline, Week 4

Perceived stress will be assessed using the 14-item Perceived Stress Scale (PSS-14). Each item is rated on a 5-point Likert scale ranging from 0 (never) to 4 (very often). Total scores range from 0 to 56, with higher scores indicating greater perceived stress. The outcome will be assessed as the change in total PSS-14 score from baseline to Week 4. A decrease in the total score indicates a reduction in perceived stress.

Baseline, Week 4

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in WHO-5 Well-Being Index Score From Baseline to Week 4
Tidsramme: Baseline, Week 4

Mental well-being will be assessed using the World Health Organization-Five Well-Being Index (WHO-5). The instrument consists of five items, each scored from 0 (at no time) to 5 (all of the time). The raw total score ranges from 0 to 25, with higher scores indicating better mental well-being. The outcome will be assessed as the change in the raw total WHO-5 score from baseline to Week 4. An increase in the score indicates improved mental well-being.

Baseline, Week 4
Secondary Outcome 2 - Quality of Life (SF-36)
Tidsramme: Baseline, Week 4

Health-related quality of life will be assessed using the 36-Item Short Form Health Survey (SF-36). The instrument consists of 36 items evaluating eight domains: physical functioning, role limitations due to physical health, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Each domain is scored separately from 0 to 100, with higher scores indicating better health-related quality of life. Changes in the eight domain scores from baseline to Week 4 will be evaluated. The SF-36 does not provide a single overall total score.

Baseline, Week 4

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

16. november 2026

Primær fullføring (Antatt)

16. november 2027

Studiet fullført (Antatt)

16. november 2027

Datoer for studieregistrering

Først innsendt

10. november 2026

Først innsendt som oppfylte QC-kriteriene

14. november 2026

Først lagt ut (Faktiske)

17. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

17. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

14. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • T2DM-478-RCT-2026

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .